2020 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y(12) Receptor Antagonists in the Asia-Pacific Region

The unique characteristics of patients with acute coronary syndrome in the Asia-Pacific region mean that international guidelines on the use of dual antiplatelet therapy (DAPT) cannot be routinely applied to these populations. Newer generation P2Y(12) inhibitors (i.e. ticagrelor and prasugrel) have...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Cardiol
Autors principals: Tan, Jack WC, Chew, Derek P, Abdul Kader, Muhamad Ali SK, Ako, Junya, Bahl, Vinay K, Chan, Mark, Park, Kyung Woo, Chandra, Praveen, Hsieh, I-Chang, Huan, Do Quang, Johar, Sofian, Juzar, Dafsah Arifa, Kim, Byeong-Keuk, Lee, Cheol Whan, Lee, Michael Kang-Yin, Li, Yi-Heng, Almahmeed, Wael, Sison, Eric Oliver, Tan, Doreen, Wang, Yu-Chen, Yeh, Shiuan Jong, Montalescot, Gilles
Format: Artigo
Idioma:Inglês
Publicat: Radcliffe Cardiology 2021
Matèries:
APSC Consensus Statements
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7941380/
https://ncbi.nlm.nih.gov/pubmed/33708263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/ecr.2020.40
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars